Gut microbiota supportive dietary pattern associated with reduced MASLD risk mediated by metabolomic profiles: a prospective cohort study
Open Access
- 5 March 2026
- journal article
- Published by Springer Nature in Nutrition Journal
- Vol. 25 (1)
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects 38% of adults worldwide. While diet influences MASLD development through multiple pathways, the role of gut microbiota-targeted dietary patterns remains unclear. We aimed to investigate the association between Dietary Index for Gut Microbiota (DI-GM) and incident MASLD risk, and to identify metabolomic signatures that may mediate this relationship. We analyzed data from 100,953 UK Biobank participants with detailed dietary and metabolomic information. The DI-GM was calculated based on 14 food components with established effects on gut microbiota. Plasma metabolomic profiling was performed using NMR spectroscopy. A metabolic signature was derived through LASSO regression with cross-validation. Cox proportional hazards models were employed to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for incident MASLD. During a median follow-up of 13.46 years, 1,221 cases of MASLD were documented. Each one-point increase in DI-GM was associated with a 15% reduction in MASLD risk (HR: 0.85, 95% CI: 0.80–0.90). Participants in the highest DI-GM (≥ 7) had a HR of 0.68 (95% CI: 0.58–0.80) compared to the lowest (≤ 4). The metabolomic analysis identified a signature of 92 metabolites strongly correlated with DI-GM (r = 0.30, P < 0.001). This signature was associated with a 26% reduction in MASLD risk per standard deviation increase (HR: 0.74, 95% CI: 0.69–0.79). Mediation analysis revealed that the metabolic signature explained 34.2% (95% CI: 19.3%–60.6%) of the association between DI-GM and MASLD risk. Higher adherence to a gut microbiota supportive dietary pattern is associated with reduced risk of MASLD. The association is partially mediated through favorable alterations in metabolism. These findings support the implementation of gut microbiota-focused dietary strategies for chronic liver disease prevention. The online version contains supplementary material available at 10.1186/s12937-026-01297-8.Keywords
This publication has 55 references indexed in Scilit:
- Plasma metabolomic signature of a proinflammatory diet in relation to breast cancer risk: a prospective cohort studyThe American Journal of Clinical Nutrition, 2025
- The effects of saturated and unsaturated fatty acids on MASLD: a Mendelian randomization analysis and in vivo experimentEuropean Journal of Nutrition, 2024
- The sulfur microbial diet and risk of nonalcoholic fatty liver disease: a prospective gene–diet study from the UK BiobankThe American Journal of Clinical Nutrition, 2023
- Short-Chain Fatty Acids—A Product of the Microbiome and Its Participation in Two-Way Communication on the Microbiome-Host Mammal LineCurrent Obesity Reports, 2023
- Diets, Gut Microbiota and MetabolitesPhenomics, 2023
- Gut-microbiota-targeted diets modulate human immune statusCell, 2021
- Description of the updated nutrition calculation of the Oxford WebQ questionnaire and comparison with the previous version among 207,144 participants in UK BiobankEuropean Journal of Nutrition, 2021
- Metabolomics‐Based Dietary Biomarkers in Nutritional Epidemiology—Current Status and Future OpportunitiesMolecular Nutrition & Food Research, 2018
- Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosisHepatology, 2017
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiotaHepatology, 2015